Φορτώνει......
Worse Outcomes for Head and Neck Rhabdomyosarcoma Secondary to Reduced-dose Cyclophosphamide
PURPOSE: Recent trends including the use of proton therapy and administration of reduced-doses of cyclophosphamide have been adapted in head and neck rhabdomyosarcoma (HN-RMS) to reduce late morbidity. Our primary goal was to analyze local control and survival outcomes after photon versus proton irr...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Int J Radiat Oncol Biol Phys |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6441953/ https://ncbi.nlm.nih.gov/pubmed/30508617 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2018.11.049 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|